Back to All Events

Harnessing Liquid Biopsies to Transform Cancer Treatment Selection, Monitoring & Early Detection and Empower Precision Treatments

  • Liquid Biopsy for Precision Oncology Summit 2024 San Diego, CA United States (map)

In this talk at the 2024 Liquid Biopsy for Precision Oncology Summit, BLOODPAC’s Executive Director Lauren C. Leiman will discuss the consortium’s work in:

  • Investigating the use of liquid biopsy for diagnosis and determining disease severity

  • Discussing recent collaborations and new guidelines for standardizations to set a regulatory precedent

  • Furthering global implementation of frameworks and standards

  • Evolving to support the community with emerging trends and technologies in liquid biopsy

Previous
February 13

BLOODPAC Q1 2024 Meeting
Next
February 29

Panel Discussion: Creating Awareness Amongst Decision-Makers on Local & Global Disparities in Liquid Biopsy Research and Practice to Shape an Inclusive Future for Understudied Diseases